Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Maximos Frountzas, Konstantinos Apostolou, Dimitrios Schizas. Cancer Manag Res 2022
Times Cited: 1
Times Cited: 1
Times Cited
Times Co-cited
Similarity
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial.
Richard S Finn, Baek-Yeol Ryoo, Philippe Merle, Masatoshi Kudo, Mohamed Bouattour, Ho Yeong Lim, Valeriy Breder, Julien Edeline, Yee Chao, Sadahisa Ogasawara,[...]. J Clin Oncol 2020
Richard S Finn, Baek-Yeol Ryoo, Philippe Merle, Masatoshi Kudo, Mohamed Bouattour, Ho Yeong Lim, Valeriy Breder, Julien Edeline, Yee Chao, Sadahisa Ogasawara,[...]. J Clin Oncol 2020
100
Molecular classifications of gastric cancers: Novel insights and possible future applications.
Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino,[...]. World J Gastrointest Oncol 2017
Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino,[...]. World J Gastrointest Oncol 2017
100
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.
Divya Thomas, Prakash Radhakrishnan. Mol Cancer 2019
Divya Thomas, Prakash Radhakrishnan. Mol Cancer 2019
100
PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.
Lihu Gu, Manman Chen, Dongyu Guo, Hepan Zhu, Wenchao Zhang, Junhai Pan, Xin Zhong, Xinlong Li, Haoran Qian, Xianfa Wang. PLoS One 2017
Lihu Gu, Manman Chen, Dongyu Guo, Hepan Zhu, Wenchao Zhang, Junhai Pan, Xin Zhong, Xinlong Li, Haoran Qian, Xianfa Wang. PLoS One 2017
100
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue, Hiroyoshi Nishikawa. Cancer Sci 2019
Yoshihiro Ohue, Hiroyoshi Nishikawa. Cancer Sci 2019
100
Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).
Kit Man Wong, Kathryn J Horton, Andrew L Coveler, Sunil R Hingorani, William P Harris. Curr Oncol Rep 2017
Kit Man Wong, Kathryn J Horton, Andrew L Coveler, Sunil R Hingorani, William P Harris. Curr Oncol Rep 2017
100
The Role of Tumor Microenvironment in Cancer Immunotherapy.
Timothy Frankel, Mirna Perusina Lanfranca, Weiping Zou. Adv Exp Med Biol 2017
Timothy Frankel, Mirna Perusina Lanfranca, Weiping Zou. Adv Exp Med Biol 2017
100
MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
Jung-ah Cho, Yeong-Shin Lee, Soo-Hyun Kim, Jin-Kyung Ko, Chul-Woo Kim. Cancer Lett 2009
Jung-ah Cho, Yeong-Shin Lee, Soo-Hyun Kim, Jin-Kyung Ko, Chul-Woo Kim. Cancer Lett 2009
100
The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors.
Evangelos Koustas, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Biomolecules 2020
Evangelos Koustas, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Biomolecules 2020
100
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer.
Toru Masuzawa, Yoshiyuki Fujiwara, Kaoru Okada, Ayumu Nakamura, Shuji Takiguchi, Kiyokazu Nakajima, Hiroshi Miyata, Makoto Yamasaki, Yukinori Kurokawa, Ryuji Osawa,[...]. Int J Oncol 2012
Toru Masuzawa, Yoshiyuki Fujiwara, Kaoru Okada, Ayumu Nakamura, Shuji Takiguchi, Kiyokazu Nakajima, Hiroshi Miyata, Makoto Yamasaki, Yukinori Kurokawa, Ryuji Osawa,[...]. Int J Oncol 2012
100
Oncolytic vaccinia virus for the treatment of cancer.
Kilian Guse, Vincenzo Cerullo, Akseli Hemminki. Expert Opin Biol Ther 2011
Kilian Guse, Vincenzo Cerullo, Akseli Hemminki. Expert Opin Biol Ther 2011
100
Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy.
Jeong Heo, Caroline J Breitbach, Anne Moon, Chang Won Kim, Rick Patt, Mi Kyung Kim, Yu Kyung Lee, Sung Yong Oh, Hyun Young Woo, Kelley Parato,[...]. Mol Ther 2011
Jeong Heo, Caroline J Breitbach, Anne Moon, Chang Won Kim, Rick Patt, Mi Kyung Kim, Yu Kyung Lee, Sung Yong Oh, Hyun Young Woo, Kelley Parato,[...]. Mol Ther 2011
100
Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma.
Clifford Akateh, Aslam M Ejaz, Timothy Michael Pawlik, Jordan M Cloyd. World J Hepatol 2020
Clifford Akateh, Aslam M Ejaz, Timothy Michael Pawlik, Jordan M Cloyd. World J Hepatol 2020
100
Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients.
Lawrence G Lum, Archana Thakur, Minsig Choi, Abhinav Deol, Vidya Kondadasula, Dana Schalk, Kristie Fields, Melissa Dufrense, Philip Philip, Gregory Dyson,[...]. Oncoimmunology 2020
Lawrence G Lum, Archana Thakur, Minsig Choi, Abhinav Deol, Vidya Kondadasula, Dana Schalk, Kristie Fields, Melissa Dufrense, Philip Philip, Gregory Dyson,[...]. Oncoimmunology 2020
100
Combination of CTLA-4 and PD-1 blockers for treatment of cancer.
Anand Rotte. J Exp Clin Cancer Res 2019
Anand Rotte. J Exp Clin Cancer Res 2019
100
Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens.
Sandra Wagner, Christina S Mullins, Michael Linnebacher. World J Gastroenterol 2018
Sandra Wagner, Christina S Mullins, Michael Linnebacher. World J Gastroenterol 2018
100
Myeloid-Derived Suppressor Cells in Colorectal Cancer.
Izabela Sieminska, Jarek Baran. Front Immunol 2020
Izabela Sieminska, Jarek Baran. Front Immunol 2020
100
BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.
Z Saridaki, D Papadatos-Pastos, M Tzardi, D Mavroudis, E Bairaktari, H Arvanity, E Stathopoulos, V Georgoulias, J Souglakos. Br J Cancer 2010
Z Saridaki, D Papadatos-Pastos, M Tzardi, D Mavroudis, E Bairaktari, H Arvanity, E Stathopoulos, V Georgoulias, J Souglakos. Br J Cancer 2010
100
Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
Chao Liu, Zhaoying Yao, Jianing Wang, Wen Zhang, Yan Yang, Yan Zhang, Xinliang Qu, Yubing Zhu, Jianjun Zou, Sishi Peng,[...]. Cell Death Differ 2020
Chao Liu, Zhaoying Yao, Jianing Wang, Wen Zhang, Yan Yang, Yan Zhang, Xinliang Qu, Yubing Zhu, Jianjun Zou, Sishi Peng,[...]. Cell Death Differ 2020
100
Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis.
Hui Wang, Tian Tian, Jinhua Zhang. Int J Mol Sci 2021
Hui Wang, Tian Tian, Jinhua Zhang. Int J Mol Sci 2021
100
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer.
Annie A Wu, Katherine M Bever, Won Jin Ho, Elana J Fertig, Nan Niu, Lei Zheng, Rose M Parkinson, Jennifer N Durham, Beth Onners, Anna K Ferguson,[...]. Clin Cancer Res 2020
Annie A Wu, Katherine M Bever, Won Jin Ho, Elana J Fertig, Nan Niu, Lei Zheng, Rose M Parkinson, Jennifer N Durham, Beth Onners, Anna K Ferguson,[...]. Clin Cancer Res 2020
100
Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy.
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. World J Gastrointest Oncol 2021
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. World J Gastrointest Oncol 2021
100
Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases.
Azza Abdel-Gadir, Amir H Massoud, Talal A Chatila. F1000Res 2018
Azza Abdel-Gadir, Amir H Massoud, Talal A Chatila. F1000Res 2018
100
The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance.
Douglas T Fearon. Cancer Immunol Res 2014
Douglas T Fearon. Cancer Immunol Res 2014
100
Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer.
Evangelos Koustas, Michalis V Karamouzis, Chrysovalantou Mihailidou, Dimitrios Schizas, Athanasios G Papavassiliou. Cancer Lett 2017
Evangelos Koustas, Michalis V Karamouzis, Chrysovalantou Mihailidou, Dimitrios Schizas, Athanasios G Papavassiliou. Cancer Lett 2017
100
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
. Lancet Gastroenterol Hepatol 2019
. Lancet Gastroenterol Hepatol 2019
100
Immunotherapy for hepatocellular carcinoma: Current and future.
Michael P Johnston, Salim I Khakoo. World J Gastroenterol 2019
Michael P Johnston, Salim I Khakoo. World J Gastroenterol 2019
100
An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study.
Jaffer A Ajani, J Randolph Hecht, Linus Ho, Jackie Baker, Marga Oortgiesen, Arnavaz Eduljee, Dov Michaeli. Cancer 2006
Jaffer A Ajani, J Randolph Hecht, Linus Ho, Jackie Baker, Marga Oortgiesen, Arnavaz Eduljee, Dov Michaeli. Cancer 2006
100
Oncolytic viral therapy for pancreatic cancer: current research and future directions.
Justin W Ady, Jacqueline Heffner, Elizabeth Klein, Yuman Fong. Oncolytic Virother 2014
Justin W Ady, Jacqueline Heffner, Elizabeth Klein, Yuman Fong. Oncolytic Virother 2014
100
Challenges and Opportunities for Pancreatic Cancer Immunotherapy.
Adham S Bear, Robert H Vonderheide, Mark H O'Hara. Cancer Cell 2020
Adham S Bear, Robert H Vonderheide, Mark H O'Hara. Cancer Cell 2020
100
Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer.
Elisa Grassi, Jody Corbelli, Giorgio Papiani, Maria Aurelia Barbera, Federica Gazzaneo, Stefano Tamberi. Front Oncol 2021
Elisa Grassi, Jody Corbelli, Giorgio Papiani, Maria Aurelia Barbera, Federica Gazzaneo, Stefano Tamberi. Front Oncol 2021
100
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
100
The Potential of CAR T Cell Therapy in Pancreatic Cancer.
Mehmet Akce, Mohammad Y Zaidi, Edmund K Waller, Bassel F El-Rayes, Gregory B Lesinski. Front Immunol 2018
Mehmet Akce, Mohammad Y Zaidi, Edmund K Waller, Bassel F El-Rayes, Gregory B Lesinski. Front Immunol 2018
100
Elucidating the link between collagen and pancreatic cancer: what's next?
Shin Hamada, Atsushi Masamune. Expert Rev Gastroenterol Hepatol 2018
Shin Hamada, Atsushi Masamune. Expert Rev Gastroenterol Hepatol 2018
100
Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer.
Jill P Smith, Hong Cao, Wenqiang Chen, Kanwal Mahmood, Teresa Phillips, Lynda Sutton, Allen Cato. Front Oncol 2021
Jill P Smith, Hong Cao, Wenqiang Chen, Kanwal Mahmood, Teresa Phillips, Lynda Sutton, Allen Cato. Front Oncol 2021
100
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.
Brian M Wolpin, Aram F Hezel, Thomas Abrams, Lawrence S Blaszkowsky, Jeffrey A Meyerhardt, Jennifer A Chan, Peter C Enzinger, Brittany Allen, Jeffrey W Clark, David P Ryan,[...]. J Clin Oncol 2009
Brian M Wolpin, Aram F Hezel, Thomas Abrams, Lawrence S Blaszkowsky, Jeffrey A Meyerhardt, Jennifer A Chan, Peter C Enzinger, Brittany Allen, Jeffrey W Clark, David P Ryan,[...]. J Clin Oncol 2009
100
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer.
Omid Hamid, Brianna Hoffner, Eduard Gasal, Jenny Hong, Richard D Carvajal. Cancer Immunol Immunother 2017
Omid Hamid, Brianna Hoffner, Eduard Gasal, Jenny Hong, Richard D Carvajal. Cancer Immunol Immunother 2017
100
Potential targets for pancreatic cancer immunotherapeutics.
Lindzy F Dodson, William G Hawkins, Peter Goedegebuure. Immunotherapy 2011
Lindzy F Dodson, William G Hawkins, Peter Goedegebuure. Immunotherapy 2011
100
100
TIM3 comes of age as an inhibitory receptor.
Yochai Wolf, Ana C Anderson, Vijay K Kuchroo. Nat Rev Immunol 2020
Yochai Wolf, Ana C Anderson, Vijay K Kuchroo. Nat Rev Immunol 2020
100
Current immunotherapy in gastrointestinal malignancies A Review.
Dushyant Singh Dahiya, Asim Kichloo, Jagmeet Singh, Michael Albosta, Manidhar Lekkala. J Investig Med 2021
Dushyant Singh Dahiya, Asim Kichloo, Jagmeet Singh, Michael Albosta, Manidhar Lekkala. J Investig Med 2021
100
IDO Expression in Cancer: Different Compartment, Different Functionality?
Annabel Meireson, Michael Devos, Lieve Brochez. Front Immunol 2020
Annabel Meireson, Michael Devos, Lieve Brochez. Front Immunol 2020
100
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.
Xianjie Jiang, Jie Wang, Xiangying Deng, Fang Xiong, Junshang Ge, Bo Xiang, Xu Wu, Jian Ma, Ming Zhou, Xiaoling Li,[...]. Mol Cancer 2019
Xianjie Jiang, Jie Wang, Xiangying Deng, Fang Xiong, Junshang Ge, Bo Xiang, Xu Wu, Jian Ma, Ming Zhou, Xiaoling Li,[...]. Mol Cancer 2019
100
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.
Jason Chesney, Igor Puzanov, Frances Collichio, Parminder Singh, Mohammed M Milhem, John Glaspy, Omid Hamid, Merrick Ross, Philip Friedlander, Claus Garbe,[...]. J Clin Oncol 2018
Jason Chesney, Igor Puzanov, Frances Collichio, Parminder Singh, Mohammed M Milhem, John Glaspy, Omid Hamid, Merrick Ross, Philip Friedlander, Claus Garbe,[...]. J Clin Oncol 2018
100
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Yelena Y Janjigian, Akihito Kawazoe, Patricio Yañez, Ning Li, Sara Lonardi, Oleksii Kolesnik, Olga Barajas, Yuxian Bai, Lin Shen, Yong Tang,[...]. Nature 2021
Yelena Y Janjigian, Akihito Kawazoe, Patricio Yañez, Ning Li, Sara Lonardi, Oleksii Kolesnik, Olga Barajas, Yuxian Bai, Lin Shen, Yong Tang,[...]. Nature 2021
100
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.
Alison P Klein. Nat Rev Gastroenterol Hepatol 2021
Alison P Klein. Nat Rev Gastroenterol Hepatol 2021
100
100
CAR-T Cell Therapy-An Overview of Targets in Gastric Cancer.
Dominika Bębnowska, Ewelina Grywalska, Paulina Niedźwiedzka-Rystwej, Barbara Sosnowska-Pasiarska, Jolanta Smok-Kalwat, Marcin Pasiarski, Stanisław Góźdź, Jacek Roliński, Wojciech Polkowski. J Clin Med 2020
Dominika Bębnowska, Ewelina Grywalska, Paulina Niedźwiedzka-Rystwej, Barbara Sosnowska-Pasiarska, Jolanta Smok-Kalwat, Marcin Pasiarski, Stanisław Góźdź, Jacek Roliński, Wojciech Polkowski. J Clin Med 2020
100
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer.
Howard L Kaufman, Heinz-Josef Lenz, John Marshall, Deepti Singh, Chris Garett, Christine Cripps, Malcolm Moore, Margaret von Mehren, Richard Dalfen, William J Heim,[...]. Clin Cancer Res 2008
Howard L Kaufman, Heinz-Josef Lenz, John Marshall, Deepti Singh, Chris Garett, Christine Cripps, Malcolm Moore, Margaret von Mehren, Richard Dalfen, William J Heim,[...]. Clin Cancer Res 2008
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.